{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:53:58Z","timestamp":1774886038305,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sanofi-Pasteur to Harvard Pilgrim Health Care"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T18:01:31Z","timestamp":1362592891000},"page":"2075-2079","source":"Crossref","is-referenced-by-count":23,"title":["Algorithms for identification of Guillain\u2013Barr\u00e9 Syndrome among adolescents in claims databases"],"prefix":"10.1016","volume":"31","author":[{"given":"Donnie","family":"Funch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Holick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Velentgas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"McMahill-Walraven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Gladowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Arnold","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.vaccine.2013.02.009_bib0005","first-page":"1023","article-title":"Guillain\u2013Barr\u00e9 syndrome among recipients of Menactra meningococcal conjugate vaccine\u2014United States, June\u2013July 2005","volume":"54","year":"2005","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0010","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1086\/533469","article-title":"Risk of Guillain\u2013Barr\u00e9 Syndrome following Serogroup C Meningococcal Conjugate vaccine in Quebec, Canada","volume":"46","author":"DeWals","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.009_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.aje.a009369","article-title":"Nationwide oral poliovirus vaccination campaign and the incidence of Guillain\u2013Barre syndrome","volume":"147","author":"Kinnunen","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0020","first-page":"175","article-title":"Risk of Guillain\u2013Barr\u00e9 syndrome following H1N1 influenza vaccination in Quebec","volume":"308","author":"DeWals","year":"2012","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.02.009_bib0025","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1093\/infdis\/175.Supplement_1.S151","article-title":"Assessment of Guillain\u2013Barr\u00e9 syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance","volume":"175","author":"Prevots","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00001648-199407000-00011","article-title":"Incidence of Guillain\u2013Barr\u00e9 syndrome in Ontario and Quebec, 1983\u20131989, using hospital service databases","volume":"5","author":"McLean","year":"1994","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain\u2013Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2013.02.009_bib0040","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/ana.410270704","article-title":"The epidemiology of Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Alter","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1440-1754.2005.00602.x","article-title":"Guillain\u2013Barr\u00e9 syndrome in childhood","volume":"41","author":"Ryan","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0050","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain\u2013Barr\u00e9 syndrome after influenza vaccination in adults","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0055","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.166.12.1301","article-title":"No association between immunization and Buillain\u2013Barr\u00e9 syndrome in the United Kingdom, 1992\u20132000","volume":"166","author":"Hughes","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0060","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3414\/ME0500","article-title":"Predictive value of ICD-9-CM codes used in vaccine safety research","volume":"47","author":"Mullooly","year":"2008","journal-title":"Methods Inf Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.02.009_bib0065","first-page":"1","volume":"21","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.02.009_bib0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pds.2318","article-title":"Mini-sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research","volume":"21","author":"Carnahan","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.02.009_bib0075","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/pds.3276","article-title":"Validation of a claims-based diagnostic code for Stevens\u2013Johnson syndrome in a commercially insured population","volume":"21","author":"Eisenberg","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.02.009_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pds.2329","article-title":"A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data","volume":"21","author":"Kee","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0085","series-title":"Pharmacoepidemiology","first-page":"736","article-title":"Validity of pharmacoepidemiologic drug and diagnosis data","author":"West","year":"2005"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0090","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1016\/j.vaccine.2009.06.092","article-title":"Predictive value of seizure ICD-9 codes for vaccine safety research","volume":"27","author":"Shui","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2013.02.009_bib0095","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/pds.1675","article-title":"A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study","volume":"17","author":"Velentgas","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/pds.3321","article-title":"Risk of Guillain\u2013Barr\u00e9 syndrome following meningococcal conjugate (MCV4, ACYW-135-D, Menactra) vaccination","author":"Velentgas","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0105","unstructured":"The Brighton Collaboration GBS Working Group. Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunisation safety data. Version 22, Dated July 15, 2009. http:\/\/www.brightoncollaboration.org\/internet\/en\/index\/definition_guidelines.html [accessed 22.10.09]."},{"issue":"6947","key":"10.1016\/j.vaccine.2013.02.009_bib0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","article-title":"Diagnostic tests 2: predictive values","volume":"309","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.02.009_bib0115","unstructured":"Preacher KJ. Calculation for the chi-square test: an interactive calculation for chi-square tests of goodness of fit and independence [Computer software] 2001. Available at: http:\/\/quantpsy.org."},{"key":"10.1016\/j.vaccine.2013.02.009_bib0120","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/pds.1924","article-title":"Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population","volume":"19","author":"Wahl","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1300162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1300162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T15:03:18Z","timestamp":1562770998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1300162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":24,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X1300162X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}